Chemical formula: C₁₇H₁₇ClO₆ Molecular mass: 352.766 g/mol PubChem compound: 441140
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| D01AA08 | Griseofulvin | D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AA Antibiotics |
| D01BA01 | Griseofulvin | D Dermatologicals → D01 Antifungals for dermatological use → D01B Antifungals for systemic use → D01BA Antifungals for systemic use |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| GRISOL Cutaneous spray, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| GRISEOFULVIN Film-coated tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Griseofulvin is an active ingredient of these brands:
United States (US)Australia (AU)Brazil (BR)Cyprus (CY)Ecuador (EC)Estonia (EE)Hong Kong (HK)Italy (IT)Nigeria (NG)South Africa (ZA)Turkey (TR)United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
